0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Buerger's Disease Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-25C13273
Home | Market Reports | Health| Health Conditions
Global Buerger s Disease Treatment Market Insights Forecast to 2029
BUY CHAPTERS

Global Buerger's Disease Treatment Market Research Report 2025

Code: QYRE-Auto-25C13273
Report
May 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Buerger's Disease Treatment Market

The global market for Buerger's Disease Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Berger"s disease occurs mostly in young and middle-aged men, and most of them have a history of heavy smoking. Typical manifestations are intermittent claudication, rest pain, and migratory thrombophlebitis. The disease mainly invades the limbs, especially the medium and small arteries of the lower limbs and their accompanying veins and superficial skin veins. The affected blood vessels present non-suppurative inflammation of the whole thickness of the vessel wall, and there is thrombosis in the lumen, which is progressive. Stenosis or even complete occlusion can cause limb ischemia and pain. In severe cases, ulcers and gangrene that are not easy to heal may occur in the limbs.
North American market for Buerger's Disease Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Buerger's Disease Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Buerger's Disease Treatment include FUJIFILM Holdings Corporation, General Electric, Koninklijke Philips NV, Pluristem Inc, Shimadzu Corporation, Siemens Healthcare GmbH, STEMPEUTICS RESEARCH PVT LTD, Toshiba Medical Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Buerger's Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buerger's Disease Treatment.
The Buerger's Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Buerger's Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Buerger's Disease Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Buerger's Disease Treatment Market Report

Report Metric Details
Report Name Buerger's Disease Treatment Market
Segment by Type
  • Vasodilators
  • Prostaglandins
  • Other
Segment by Application
  • Hospitals
  • Specialty Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company FUJIFILM Holdings Corporation, General Electric, Koninklijke Philips NV, Pluristem Inc, Shimadzu Corporation, Siemens Healthcare GmbH, STEMPEUTICS RESEARCH PVT LTD, Toshiba Medical Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Buerger's Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Buerger's Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Buerger's Disease Treatment Market report?

Ans: The main players in the Buerger's Disease Treatment Market are FUJIFILM Holdings Corporation, General Electric, Koninklijke Philips NV, Pluristem Inc, Shimadzu Corporation, Siemens Healthcare GmbH, STEMPEUTICS RESEARCH PVT LTD, Toshiba Medical Corporation

What are the Application segmentation covered in the Buerger's Disease Treatment Market report?

Ans: The Applications covered in the Buerger's Disease Treatment Market report are Hospitals, Specialty Clinics, Other

What are the Type segmentation covered in the Buerger's Disease Treatment Market report?

Ans: The Types covered in the Buerger's Disease Treatment Market report are Vasodilators, Prostaglandins, Other

1 Buerger's Disease Treatment Market Overview
1.1 Product Definition
1.2 Buerger's Disease Treatment by Type
1.2.1 Global Buerger's Disease Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vasodilators
1.2.3 Prostaglandins
1.2.4 Other
1.3 Buerger's Disease Treatment by Application
1.3.1 Global Buerger's Disease Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Other
1.4 Global Buerger's Disease Treatment Market Size Estimates and Forecasts
1.4.1 Global Buerger's Disease Treatment Revenue 2020-2031
1.4.2 Global Buerger's Disease Treatment Sales 2020-2031
1.4.3 Global Buerger's Disease Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Buerger's Disease Treatment Market Competition by Manufacturers
2.1 Global Buerger's Disease Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Buerger's Disease Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Buerger's Disease Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Buerger's Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Buerger's Disease Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Buerger's Disease Treatment, Product Type & Application
2.7 Global Key Manufacturers of Buerger's Disease Treatment, Date of Enter into This Industry
2.8 Global Buerger's Disease Treatment Market Competitive Situation and Trends
2.8.1 Global Buerger's Disease Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Buerger's Disease Treatment Players Market Share by Revenue
2.8.3 Global Buerger's Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Buerger's Disease Treatment Market Scenario by Region
3.1 Global Buerger's Disease Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Buerger's Disease Treatment Sales by Region: 2020-2031
3.2.1 Global Buerger's Disease Treatment Sales by Region: 2020-2025
3.2.2 Global Buerger's Disease Treatment Sales by Region: 2026-2031
3.3 Global Buerger's Disease Treatment Revenue by Region: 2020-2031
3.3.1 Global Buerger's Disease Treatment Revenue by Region: 2020-2025
3.3.2 Global Buerger's Disease Treatment Revenue by Region: 2026-2031
3.4 North America Buerger's Disease Treatment Market Facts & Figures by Country
3.4.1 North America Buerger's Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Buerger's Disease Treatment Sales by Country (2020-2031)
3.4.3 North America Buerger's Disease Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Buerger's Disease Treatment Market Facts & Figures by Country
3.5.1 Europe Buerger's Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Buerger's Disease Treatment Sales by Country (2020-2031)
3.5.3 Europe Buerger's Disease Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buerger's Disease Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Buerger's Disease Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Buerger's Disease Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Buerger's Disease Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Buerger's Disease Treatment Market Facts & Figures by Country
3.7.1 Latin America Buerger's Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Buerger's Disease Treatment Sales by Country (2020-2031)
3.7.3 Latin America Buerger's Disease Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Buerger's Disease Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Buerger's Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Buerger's Disease Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Buerger's Disease Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Buerger's Disease Treatment Sales by Type (2020-2031)
4.1.1 Global Buerger's Disease Treatment Sales by Type (2020-2025)
4.1.2 Global Buerger's Disease Treatment Sales by Type (2026-2031)
4.1.3 Global Buerger's Disease Treatment Sales Market Share by Type (2020-2031)
4.2 Global Buerger's Disease Treatment Revenue by Type (2020-2031)
4.2.1 Global Buerger's Disease Treatment Revenue by Type (2020-2025)
4.2.2 Global Buerger's Disease Treatment Revenue by Type (2026-2031)
4.2.3 Global Buerger's Disease Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Buerger's Disease Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Buerger's Disease Treatment Sales by Application (2020-2031)
5.1.1 Global Buerger's Disease Treatment Sales by Application (2020-2025)
5.1.2 Global Buerger's Disease Treatment Sales by Application (2026-2031)
5.1.3 Global Buerger's Disease Treatment Sales Market Share by Application (2020-2031)
5.2 Global Buerger's Disease Treatment Revenue by Application (2020-2031)
5.2.1 Global Buerger's Disease Treatment Revenue by Application (2020-2025)
5.2.2 Global Buerger's Disease Treatment Revenue by Application (2026-2031)
5.2.3 Global Buerger's Disease Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Buerger's Disease Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 FUJIFILM Holdings Corporation
6.1.1 FUJIFILM Holdings Corporation Company Information
6.1.2 FUJIFILM Holdings Corporation Description and Business Overview
6.1.3 FUJIFILM Holdings Corporation Buerger's Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 FUJIFILM Holdings Corporation Buerger's Disease Treatment Product Portfolio
6.1.5 FUJIFILM Holdings Corporation Recent Developments/Updates
6.2 General Electric
6.2.1 General Electric Company Information
6.2.2 General Electric Description and Business Overview
6.2.3 General Electric Buerger's Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 General Electric Buerger's Disease Treatment Product Portfolio
6.2.5 General Electric Recent Developments/Updates
6.3 Koninklijke Philips NV
6.3.1 Koninklijke Philips NV Company Information
6.3.2 Koninklijke Philips NV Description and Business Overview
6.3.3 Koninklijke Philips NV Buerger's Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Koninklijke Philips NV Buerger's Disease Treatment Product Portfolio
6.3.5 Koninklijke Philips NV Recent Developments/Updates
6.4 Pluristem Inc
6.4.1 Pluristem Inc Company Information
6.4.2 Pluristem Inc Description and Business Overview
6.4.3 Pluristem Inc Buerger's Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pluristem Inc Buerger's Disease Treatment Product Portfolio
6.4.5 Pluristem Inc Recent Developments/Updates
6.5 Shimadzu Corporation
6.5.1 Shimadzu Corporation Company Information
6.5.2 Shimadzu Corporation Description and Business Overview
6.5.3 Shimadzu Corporation Buerger's Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shimadzu Corporation Buerger's Disease Treatment Product Portfolio
6.5.5 Shimadzu Corporation Recent Developments/Updates
6.6 Siemens Healthcare GmbH
6.6.1 Siemens Healthcare GmbH Company Information
6.6.2 Siemens Healthcare GmbH Description and Business Overview
6.6.3 Siemens Healthcare GmbH Buerger's Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Siemens Healthcare GmbH Buerger's Disease Treatment Product Portfolio
6.6.5 Siemens Healthcare GmbH Recent Developments/Updates
6.7 STEMPEUTICS RESEARCH PVT LTD
6.7.1 STEMPEUTICS RESEARCH PVT LTD Company Information
6.7.2 STEMPEUTICS RESEARCH PVT LTD Description and Business Overview
6.7.3 STEMPEUTICS RESEARCH PVT LTD Buerger's Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 STEMPEUTICS RESEARCH PVT LTD Buerger's Disease Treatment Product Portfolio
6.7.5 STEMPEUTICS RESEARCH PVT LTD Recent Developments/Updates
6.8 Toshiba Medical Corporation
6.8.1 Toshiba Medical Corporation Company Information
6.8.2 Toshiba Medical Corporation Description and Business Overview
6.8.3 Toshiba Medical Corporation Buerger's Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Toshiba Medical Corporation Buerger's Disease Treatment Product Portfolio
6.8.5 Toshiba Medical Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buerger's Disease Treatment Industry Chain Analysis
7.2 Buerger's Disease Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buerger's Disease Treatment Production Mode & Process Analysis
7.4 Buerger's Disease Treatment Sales and Marketing
7.4.1 Buerger's Disease Treatment Sales Channels
7.4.2 Buerger's Disease Treatment Distributors
7.5 Buerger's Disease Treatment Customer Analysis
8 Buerger's Disease Treatment Market Dynamics
8.1 Buerger's Disease Treatment Industry Trends
8.2 Buerger's Disease Treatment Market Drivers
8.3 Buerger's Disease Treatment Market Challenges
8.4 Buerger's Disease Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Buerger's Disease Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Buerger's Disease Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Buerger's Disease Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Buerger's Disease Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Buerger's Disease Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Buerger's Disease Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Buerger's Disease Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Buerger's Disease Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Buerger's Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Buerger's Disease Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Buerger's Disease Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Buerger's Disease Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Buerger's Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buerger's Disease Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Buerger's Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Buerger's Disease Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Buerger's Disease Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Buerger's Disease Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Buerger's Disease Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Buerger's Disease Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Buerger's Disease Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Buerger's Disease Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Buerger's Disease Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Buerger's Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Buerger's Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Buerger's Disease Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Buerger's Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Buerger's Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Buerger's Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Buerger's Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Buerger's Disease Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Buerger's Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Buerger's Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Buerger's Disease Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Buerger's Disease Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Buerger's Disease Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Buerger's Disease Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Buerger's Disease Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Buerger's Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Buerger's Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Buerger's Disease Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Buerger's Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Buerger's Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Buerger's Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Buerger's Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Buerger's Disease Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Buerger's Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Buerger's Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Buerger's Disease Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Buerger's Disease Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Buerger's Disease Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Buerger's Disease Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Buerger's Disease Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Buerger's Disease Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Buerger's Disease Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Buerger's Disease Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Buerger's Disease Treatment Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Buerger's Disease Treatment Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Buerger's Disease Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Buerger's Disease Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Buerger's Disease Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Buerger's Disease Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Buerger's Disease Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Buerger's Disease Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Buerger's Disease Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Buerger's Disease Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Buerger's Disease Treatment Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Buerger's Disease Treatment Price (US$/Unit) by Application (2026-2031)
 Table 70. FUJIFILM Holdings Corporation Company Information
 Table 71. FUJIFILM Holdings Corporation Description and Business Overview
 Table 72. FUJIFILM Holdings Corporation Buerger's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. FUJIFILM Holdings Corporation Buerger's Disease Treatment Product
 Table 74. FUJIFILM Holdings Corporation Recent Developments/Updates
 Table 75. General Electric Company Information
 Table 76. General Electric Description and Business Overview
 Table 77. General Electric Buerger's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. General Electric Buerger's Disease Treatment Product
 Table 79. General Electric Recent Developments/Updates
 Table 80. Koninklijke Philips NV Company Information
 Table 81. Koninklijke Philips NV Description and Business Overview
 Table 82. Koninklijke Philips NV Buerger's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Koninklijke Philips NV Buerger's Disease Treatment Product
 Table 84. Koninklijke Philips NV Recent Developments/Updates
 Table 85. Pluristem Inc Company Information
 Table 86. Pluristem Inc Description and Business Overview
 Table 87. Pluristem Inc Buerger's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pluristem Inc Buerger's Disease Treatment Product
 Table 89. Pluristem Inc Recent Developments/Updates
 Table 90. Shimadzu Corporation Company Information
 Table 91. Shimadzu Corporation Description and Business Overview
 Table 92. Shimadzu Corporation Buerger's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Shimadzu Corporation Buerger's Disease Treatment Product
 Table 94. Shimadzu Corporation Recent Developments/Updates
 Table 95. Siemens Healthcare GmbH Company Information
 Table 96. Siemens Healthcare GmbH Description and Business Overview
 Table 97. Siemens Healthcare GmbH Buerger's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Siemens Healthcare GmbH Buerger's Disease Treatment Product
 Table 99. Siemens Healthcare GmbH Recent Developments/Updates
 Table 100. STEMPEUTICS RESEARCH PVT LTD Company Information
 Table 101. STEMPEUTICS RESEARCH PVT LTD Description and Business Overview
 Table 102. STEMPEUTICS RESEARCH PVT LTD Buerger's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. STEMPEUTICS RESEARCH PVT LTD Buerger's Disease Treatment Product
 Table 104. STEMPEUTICS RESEARCH PVT LTD Recent Developments/Updates
 Table 105. Toshiba Medical Corporation Company Information
 Table 106. Toshiba Medical Corporation Description and Business Overview
 Table 107. Toshiba Medical Corporation Buerger's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Toshiba Medical Corporation Buerger's Disease Treatment Product
 Table 109. Toshiba Medical Corporation Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Buerger's Disease Treatment Distributors List
 Table 113. Buerger's Disease Treatment Customers List
 Table 114. Buerger's Disease Treatment Market Trends
 Table 115. Buerger's Disease Treatment Market Drivers
 Table 116. Buerger's Disease Treatment Market Challenges
 Table 117. Buerger's Disease Treatment Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Buerger's Disease Treatment
 Figure 2. Global Buerger's Disease Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Buerger's Disease Treatment Market Share by Type: 2024 & 2031
 Figure 4. Vasodilators Product Picture
 Figure 5. Prostaglandins Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Buerger's Disease Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Buerger's Disease Treatment Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Specialty Clinics
 Figure 11. Other
 Figure 12. Global Buerger's Disease Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Buerger's Disease Treatment Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Buerger's Disease Treatment Sales (2020-2031) & (K Units)
 Figure 15. Global Buerger's Disease Treatment Average Price (US$/Unit) & (2020-2031)
 Figure 16. Buerger's Disease Treatment Report Years Considered
 Figure 17. Buerger's Disease Treatment Sales Share by Manufacturers in 2024
 Figure 18. Global Buerger's Disease Treatment Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Buerger's Disease Treatment Players: Market Share by Revenue in Buerger's Disease Treatment in 2024
 Figure 20. Buerger's Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Buerger's Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Buerger's Disease Treatment Sales Market Share by Country (2020-2031)
 Figure 23. North America Buerger's Disease Treatment Revenue Market Share by Country (2020-2031)
 Figure 24. United States Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Buerger's Disease Treatment Sales Market Share by Country (2020-2031)
 Figure 27. Europe Buerger's Disease Treatment Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Buerger's Disease Treatment Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Buerger's Disease Treatment Revenue Market Share by Region (2020-2031)
 Figure 35. China Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Buerger's Disease Treatment Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Buerger's Disease Treatment Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Buerger's Disease Treatment Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Buerger's Disease Treatment Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Buerger's Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Buerger's Disease Treatment by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Buerger's Disease Treatment by Type (2020-2031)
 Figure 54. Global Buerger's Disease Treatment Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Buerger's Disease Treatment by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Buerger's Disease Treatment by Application (2020-2031)
 Figure 57. Global Buerger's Disease Treatment Price (US$/Unit) by Application (2020-2031)
 Figure 58. Buerger's Disease Treatment Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart